MYC and cancer: Studies in cancer cell lines have demonstrated that the sensitivity of particular cell lines to the growth-restricting effects of BET inhibitors correlated with the activity of super enhancers proximal to key oncogenic driver genes (such as c-myc) [1,21,22].